TENIVAC vaccine contraindications and precautions (Please see Sanofi Pasteur product insert for complete list):
-
- Serious allergic or hypersensitivity reaction to a previous shot, or to any diphtheria or tetanus toxoid vaccine;
- If Guillain-Barré Syndrome (GBS) occurred within six weeks of a previous tetanus toxoid vaccine, the decision to administer TENIVAC should carefully examine the possible risk and benefits prior to vaccination;
- Anyone who has experienced an Arthus-type hypersensitivity reaction following a previous dose of a tetanus toxoid vaccine should not receive TENIVAC more frequently than every 10 years;
- The tip caps of prefilled TENIVAC syringes contain latex and may cause an allergic reaction in persons sensitive to latex;
- Administering TENIVAC vaccine more frequently than prescribed may result in the increased incidence and severity of adverse reactions.
TENIVAC is approved for use in adults and children seven years of age and older. TENIVAC should not be administered to children younger than seven years.
